Even though recipient BALB/c mice given Itk–/– canonical Tregs initially showed minimal signs of GVHD, similar to those given Itk–/– noncanonical Tregs, we observed increased signs of GVHD after 35 days (Figure 3C). This evidence concerns the gene ITK and graft versus host disease.